Port-A-Cath usage in children with haemophilia: experience of 53 cases.
about
Paediatric care of the child with haemophilia.Prophylaxis in developed and in emerging countries.Haemophilia 2002: emerging risks of treatment.Barriers to primary prophylaxis in haemophilic children: the issue of the venous access.When to start and when to stop primary prophylaxis in patients with severe haemophilia.Central venous lines in haemophilia.Home management of haemophilia.Central venous access devices in haemophilia.Consensus recommendations for use of central venous access devices in haemophilia.Optimizing factor prophylaxis for the haemophilia population: where do we stand?Barriers and perceived limitations to early treatment of hemophilia.Complications of central venous access devices in paediatric haemophilia patients.Experience with a new percutaneous port system, Percuseal, for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1-antitrypsin deficiency.Fatal central venous catheter-related infection in haemophilia.A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres.How to start prophylaxis.Inadvertent anticoagulation of a haemophiliac child with routine line flushing.Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized.Central venous catheter-related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitors.Surveillance of infectious complications associated with central venous access devices in children with haemophilia.Second Workshop of the European Paediatric Network for Haemophilia Management, 17-19 September 1998 in Vitznau/Switzerland.A survey of factor prophylaxis in the Canadian haemophilia A population.Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.Complications of central venous catheters in patients with haemophilia and inhibitors.Aspects of haemophilia prophylaxis in Sweden.Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
P2860
Q34636870-1F5E0405-B661-4769-8169-5BEB6145B197Q34636878-1A01A8C1-48DC-4381-A5AC-507E3B250D85Q34636927-4139534C-195E-4416-A787-C90195894BB1Q34910120-83255819-E61E-4E74-9EE7-3726652EF6D3Q35112433-8D1BD84F-E57B-4140-803A-765ADC21F1D1Q35112454-AAE0F3F9-4B46-4ADA-843C-19EB53A3FB31Q35666730-7390AD5A-6AB3-46FD-95E7-F036F761A778Q35666735-38856FA9-886F-49DE-9B8D-30287BCC891DQ35882783-875DCB67-E9B6-4916-9243-CA1AFE89DBEFQ35915686-7D390FE5-1DC7-471D-A25C-AE48ED9FB092Q36863077-265D2C41-7520-4FD1-9913-C1BC422ED0D1Q40607590-D5A81CCB-2F06-4CD4-A1F7-423B4487DD7AQ44676673-7F18444A-C88D-4B50-9DAC-3E09A24ACD68Q45856110-071D9568-FFFF-46AD-9C6D-A7D62648E7B7Q45861791-2A0358A2-7C9C-49AD-A022-1ED5931E7577Q45861823-FA0C3385-508A-4121-B8C3-9F58EDA167E4Q45861886-D0C07829-A823-4966-A4C4-A9F4D68AB113Q45863345-51EE0979-906E-4150-8FB2-5A0675A66508Q45868966-D613465B-79EF-4414-9FA5-6294AC71AB11Q45868978-4ABBB36A-32B5-4D2B-9003-0D2EE4C6E505Q45870272-30555E5C-BC19-4F1D-A377-C70045BEB3D9Q45879726-121B1461-7983-4661-B2E8-891D161AD7E2Q45883398-FA549753-E6B2-4CB7-84E7-C30ACF9EF0A1Q45883471-0319F733-E00D-447C-95B6-8273F7C21738Q45885381-AC97F0A9-D526-40F1-9BB5-8A9E6C81F451Q50718662-BB905886-8C5C-4ACB-BDFF-8EF435CE27BE
P2860
Port-A-Cath usage in children with haemophilia: experience of 53 cases.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Port-A-Cath usage in children with haemophilia: experience of 53 cases.
@en
Port-A-Cath usage in children with haemophilia: experience of 53 cases.
@nl
type
label
Port-A-Cath usage in children with haemophilia: experience of 53 cases.
@en
Port-A-Cath usage in children with haemophilia: experience of 53 cases.
@nl
prefLabel
Port-A-Cath usage in children with haemophilia: experience of 53 cases.
@en
Port-A-Cath usage in children with haemophilia: experience of 53 cases.
@nl
P2093
P1433
P1476
Port-A-Cath usage in children with haemophilia: experience of 53 cases.
@en
P2093
Effenberger W
Kekomäki R
Scheibel E
Tengborn L
van den Berg M
P304
P356
10.1080/080352598750031365
P407
P577
1998-10-01T00:00:00Z